TEVA as equity financer????, page-182

No, @dolcevita. I come here with an open mind and if I read something that might throw a new light on a topic I pay it the respect of including it in what sways my sentiment.

"So a high volume of posts going on about the same thing, can sway sentiment?" That would be to mistake quantity for quality. It's not the volume, it's the content. It's obvious that I maintain a strong bias in favour of MSB's success but my personal prism is all about the science. @madamswer and others have enlightened me, to my discomfort, to the fact that an underfunded company can have to give itself away in order to raise cash for ongoing activities and it's the late-coming investors who reap the benefits. Of course, through my rosy glasses I "see" the possibility that cash injections from partnerships in spine, R.A., Crohn's, acute GvHD and other indications might avoid or reduce reliance on the equity funding, but that's just a hope until it occurs.